A class action lawsuit was filed against Merck & Co. (MRK) by Levi & Korsinsky on February 12, 2025. The plaintiffs ...

Bernstein analyst Florent Cespedes maintained a Hold rating on Merck KGaA (0O14 – Research Report) today and set a price target of €168.00. The ...

Semarion's SemaCyte® technology transforms adherent cell assays, enabling faster, automated workflows that enhance ...

The semiconductor, electronics, and pharmaceutical industries play a vital role in the global high-purity sulfuric acid ...

Revenue: €2.81b (up 19% from FY 2023). Net income: €318.9m (up 16% from FY 2023). Profit margin: 11% (in line with FY 2023). EPS: €3.32 (up from €2.86 in FY 2023). Revenue was in line with ...

Revenue: €2.81b (up 19% from FY 2023). Net income: €318.9m (up 16% from FY 2023). Profit margin: 11% (in line with FY 2023). EPS: €3.32 (up from €2.86 in FY 2023). Revenue was in line with analyst ...

id=8484789 As of 2023, prominent players in analytical standards are Merck KGaA (Germany), Agilent Technologies, Inc. (US), Waters Corporation (US), LGC Limited (UK), PerkinElmer (US), Restek ...

The global Analytical Standards Market, valued at US$1.44 billion in 2022, is forecasted to grow at a robust CAGR of 5.9%, reaching ...

Merck & Co said on Thursday that it plans to launch a subcutaneously injected version of its blockbuster cancer immunotherapy Keytruda in the U.S. on October 1, and expects to hit peak adoption rates ...

Merck released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA ...